A cancer diagnosis is one of the most overwhelming moments a person can face. Alongside the emotional weight comes an avalanche of medical terminology, treatment options, and decisions that feel far too large to navigate alone. Three types of cancer treatment you are likely to hear early and often are chemotherapy, immunotherapy, and targeted therapy. Each works differently, suits different types of cancer, and carries its own set of benefits and side effects. Knowing what each treatment actually does, and why a doctor might recommend one over another, can help you feel far less lost in those early conversations. This blog breaks down all three in plain language, so you can walk into the oncologist’s appointment better informed and more confident.
What is Chemotherapy?
Chemotherapy is one of the oldest and most widely used cancer treatments in the world. It works by using powerful drugs to destroy rapidly dividing cells throughout the body. Developed over several decades, it remains a cornerstone of cancer care globally and continues to save lives every day.
How it works: Chemotherapy drugs travel through the bloodstream and attack cells that are dividing quickly, which includes most cancer cells. However, because it is not selective, it also affects healthy fast-dividing cells such as those in the hair follicles, digestive tract, and bone marrow. This is why it tends to carry a broader range of side effects compared to newer treatments.
Common side effects include:
- Nausea and vomiting
- Hair loss
- Fatigue
- Increased risk of infection
- Mouth sores
- Anaemia
When is it used? Chemotherapy remains a frontline treatment for many cancers, including leukaemia, lymphoma, breast cancer, and lung cancer. It can be used to shrink tumours before surgery (known as neoadjuvant therapy), destroy remaining cancer cells after surgery (adjuvant therapy), or as the primary treatment when surgery is not possible. For some patients, it is also used palliatively to manage symptoms and slow disease progression.
What Is Immunotherapy?
Immunotherapy is a newer and rapidly evolving approach that works with your own immune system rather than against cancer directly.
How it works: Your immune system naturally identifies and destroys abnormal cells, but cancer often finds ways to disguise itself or suppress immune responses. Immunotherapy drugs, such as checkpoint inhibitors, essentially “unmask” the cancer cells, allowing the immune system to recognise and attack them.
Common side effects include:
- Skin rashes
- Fatigue
- Flu-like symptoms
- Inflammation in the lungs, liver, or other organs
- Diarrhoea
When is it used? Immunotherapy has shown remarkable results in melanoma, non-small cell lung cancer, bladder cancer, and certain types of head and neck cancers. It is particularly effective in patients whose tumours express specific proteins, such as PD-L1, which can be identified through biomarker testing. One of the most exciting aspects of immunotherapy is its potential for long-lasting responses, with some patients experiencing remission that extends well beyond the treatment period itself.
What Is Targeted Therapy?
Targeted therapy is perhaps the most precise of the three. Rather than attacking all dividing cells or boosting the immune system broadly, it homes in on specific molecular changes within cancer cells. Think of it as a precisely aimed intervention rather than a broad sweep.
How it works: Cancer cells often carry genetic mutations or proteins that drive their uncontrolled growth. Targeted therapy drugs are designed to block these specific signals, essentially switching off the cancer’s ability to grow and spread. Because healthy cells typically do not carry these same mutations, targeted therapy tends to cause less collateral damage than chemotherapy.
Common side effects include:
- Skin problems and rashes
- High blood pressure
- Liver issues
- Diarrhoea
- Fatigue
When is it used? Targeted therapy is most effective when a tumour has a specific, identifiable mutation. It is commonly used for HER2-positive breast cancer, EGFR-mutated lung cancer, certain types of leukaemia, and BRAF-mutated melanoma. Genetic testing of the tumour is usually required before this treatment can be recommended, which means it may not be suitable for everyone.
How Are They Different? A Quick Comparison
|
Chemotherapy |
Immunotherapy |
Targeted Therapy |
|
|---|---|---|---|
|
Approach |
Destroys dividing cells |
Boosts immune response |
Blocks specific cancer signals |
|
Selectivity |
Low |
Moderate |
High |
|
Side Effects |
Often severe |
Can be unpredictable |
Specific to the target |
|
Requires Genetic Testing |
Rarely |
Sometimes |
Usually yes |
|
Best For |
Many cancer types |
Certain cancers with immune markers |
Cancers with known mutations |
Can These Treatments Be Combined?
Absolutely, and quite commonly so. Oncologists often combine treatments to improve outcomes. Combination approaches are increasingly the norm rather than the exception, particularly as research continues to reveal how different therapies can complement one another.
- Chemotherapy and immunotherapy together have shown strong results in certain lung cancer cases.
- Targeted therapy may be used after chemotherapy if a mutation is detected in remaining cancer cells.
- Some patients receive all three at different stages of their treatment journey.
The combination used depends entirely on the type of cancer, its stage, the patient’s overall health, and the genetic profile of the tumour.
Which One Is Right for You?
There is no universal answer, and this is not a decision you should make based on a blog post alone. The right treatment depends on:
- The type and stage of your cancer
- The genetic and molecular profile of your tumour
- Your overall health and medical history
- Your personal preferences and quality-of-life priorities
What has changed dramatically in recent years is that patients now have more options than ever before. The shift towards personalised oncology means your treatment can be tailored far more precisely to your specific cancer rather than following a one-size-fits-all approach. It is always worth asking your oncologist whether genetic testing is relevant in your case, as it can open doors to treatments that might otherwise not be considered.
Conclusion
Understanding the differences between chemotherapy, immunotherapy, and targeted therapy is the first step towards becoming an active participant in your own care. Each has its place, each has its strengths, and for many patients, a combination of these approaches offers the best chance at remission or long-term management. If you are based in the NCR region and are seeking expert guidance, do not navigate this journey alone. Consult with a specialist at a reputable cancer hospital in Ghaziabad, who can make all the difference in receiving an accurate diagnosis, a thorough genetic workup, and a treatment plan that is truly built around you. The right team, with the right information, gives you the best possible foundation to fight back.
